Pharma

Your Article Summary

See Latest Articles

Angiotech receives approval for quill srs pdo, monoderm, polypropylene and nylon product lines for sale in brazil
Angiotech Pharmaceuticals, 08/14/09

Angiotech Pharmaceuticals, Inc. , announced that it has received approval to begin marketing the Quill SRS Polydioxanone (PDO), MONODERM, Polypropylene and Nylon product lines in Brazil.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09

Safety concerns slow new drug review and approval processes
Formulary , 12/02/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

 See all of Drug/Product Approvals